Can Erdafitinib be purchased on behalf of others? Analysis of formal drug purchasing channels at home and abroad

Erdafitinib is a targeted drug mainly used to treat locally advanced or metastatic urothelial cancer with positive FGFR gene mutations. The drug is already on the market in China, but has not yet been included in medical insurance, so patients may face certain difficulties in purchasing the drug. Despite this, patients can obtain drugs through some legal channels. The following is an analysis of formal drug purchase channels at home and abroad.

Currently, erdafitinib is available in China, but due to its short time on the market, it is not covered by medical insurance, so patients may need to pay for it out of pocket. Patients can obtain erdafitinib through formal channels, such as hospital pharmacies or some certified pharmaceutical agents. However, it should be noted that the domestic drug supply chain is still under construction, and there may be insufficient drug inventory or supply delays. Therefore, patients need to consult relevant hospitals or pharmacies to understand the supply status of medicines before purchasing medicines.

If there are difficulties in domestic purchasing, patients can choose overseas purchasing channels. In the overseas market, the original drug of erdafitinib is mainly produced by the Hong Kong version of China, and the price is relatively expensive, roughly around 20,000 yuan. Patients can purchase it through regular Hong Kong pharmacies or reputable drug suppliers, but they need to pay attention to whether it complies with the country's drug import regulations. It should be reminded that although Hong Kong is a special administrative region of China, some patients may face customs restrictions or other regulatory obstacles.

In contrast, generic drugs are more affordable and have basically the same ingredients as the original drugs. Currently, there are mainly Lao and Bangladeshi generic drugs on the market. The prices of these drugs usually range from a few hundred yuan to more than 2,000 yuan. Patients purchasing generic drugs through formal purchasing platforms or overseas pharmacies can effectively reduce treatment costs. Although the price of generic drugs is low, it is also necessary to ensure the legality of the drug purchase channels and the quality of the drugs.

Reference link:https://www.balversa.com/